These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37770173)

  • 1. Phage for treatment of Vibrio cholerae infection.
    Mittal M; Tripathi S; Saini A; Mani I
    Prog Mol Biol Transl Sci; 2023; 201():21-39. PubMed ID: 37770173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant
    Hays SG; Seed KD
    Elife; 2020 Apr; 9():. PubMed ID: 32329714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models.
    Yen M; Cairns LS; Camilli A
    Nat Commun; 2017 Feb; 8():14187. PubMed ID: 28146150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vibrio cholerae infection, novel drug targets and phage therapy.
    Fazil MH; Singh DV
    Future Microbiol; 2011 Oct; 6(10):1199-208. PubMed ID: 22004038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the evolutionary arms race between Vibrio cholerae and Vibriophage clinical isolates.
    Yen M; Camilli A
    Int Microbiol; 2017 Sep; 20(3):116-120. PubMed ID: 29446802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of Vibrio cholera. Editorial overview.
    Cava F
    Int Microbiol; 2017 Sep; 20(3):105. PubMed ID: 29446800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh.
    Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM
    Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic Vibrio cholerae O1 that is sensitive to Mukerjee's cholera phage IV and the phage produced by the hemolytic vibrio lysogenized with the infection of Mukerjee's cholera phage IV.
    Iwanaga M; Nakamura S; Kuyyakanond T
    Microbiol Immunol; 1989; 33(8):609-18. PubMed ID: 2779469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae.
    Faruque SM; Mekalanos JJ
    Virulence; 2012 Nov; 3(7):556-65. PubMed ID: 23076327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a phage typing scheme for Vibrio cholerae O139.
    Chakrabarti AK; Ghosh AN; Nair GB; Niyogi SK; Bhattacharya SK; Sarkar BL
    J Clin Microbiol; 2000 Jan; 38(1):44-9. PubMed ID: 10618061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization of ØVC8 lytic phage for Vibrio cholerae O1.
    Solís-Sánchez A; Hernández-Chiñas U; Navarro-Ocaña A; De la Mora J; Xicohtencatl-Cortes J; Eslava-Campos C
    Virol J; 2016 Mar; 13():47. PubMed ID: 27000701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cholera typing phages. IV. Phage-resistant mutants of Vibrio cholerae.
    MUKERJEE S
    Ann Biochem Exp Med; 1962 Jan; 22():1-4. PubMed ID: 14477037
    [No Abstract]   [Full Text] [Related]  

  • 13. Vibrio cholerae Outer Membrane Vesicles Inhibit Bacteriophage Infection.
    Reyes-Robles T; Dillard RS; Cairns LS; Silva-Valenzuela CA; Housman M; Ali A; Wright ER; Camilli A
    J Bacteriol; 2018 Aug; 200(15):. PubMed ID: 29661863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Tail Fiber Protein and a Receptor-Binding Protein Mediate ICP2 Bacteriophage Interactions with Vibrio cholerae OmpU.
    Lim ANW; Yen M; Seed KD; Lazinski DW; Camilli A
    J Bacteriol; 2021 Jun; 203(13):e0014121. PubMed ID: 33875544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly specific phage defense system is a conserved feature of the Vibrio cholerae mobilome.
    O'Hara BJ; Barth ZK; McKitterick AC; Seed KD
    PLoS Genet; 2017 Jun; 13(6):e1006838. PubMed ID: 28594826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological characterization of v. Cholerae-specific bacteriophages isolated from water sources in Georgia.
    Elbakidze T; Kokashvili T; Janelidze N; Porchkhidze K; Koberidze T; Tediashvili M
    Georgian Med News; 2015 Mar; (240):65-72. PubMed ID: 25879562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants.
    Zahid MS; Udden SM; Faruque AS; Calderwood SB; Mekalanos JJ; Faruque SM
    Infect Immun; 2008 Nov; 76(11):5266-73. PubMed ID: 18794293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of different oral approaches to treat Vibrio cholerae infection in adult mice.
    Jaiswal A; Koley H; Mitra S; Saha DR; Sarkar B
    Int J Med Microbiol; 2014 May; 304(3-4):422-30. PubMed ID: 24656386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary consequences of intra-patient phage predation on microbial populations.
    Seed KD; Yen M; Shapiro BJ; Hilaire IJ; Charles RC; Teng JE; Ivers LC; Boncy J; Harris JB; Camilli A
    Elife; 2014 Aug; 3():e03497. PubMed ID: 25161196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outer-membrane protein TolC of
    Fan F; Li X; Pang B; Zhang C; Li Z; Zhang L; Li J; Zhang J; Yan M; Liang W; Kan B
    J Biol Chem; 2018 Mar; 293(11):4000-4013. PubMed ID: 29259138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.